Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGooch & Housego Regulatory News (GHH)

Share Price Information for Gooch & Housego (GHH)

Share Price is delayed by 15 minutes
Get Live Data
848.00    22.00 (2.66%)
Bid:
848.00
Ask:
860.00
Spread: 12.00 (1.415%)
Market Cap: £232.10m
GHH Live PriceLast checked at - London Stock Exchange

Intraday Gooch & Housego Share Chart

AGM Trading Update

23 Feb 2022 07:00

RNS Number : 4740C
Gooch & Housego PLC
23 February 2022
 

 

For immediate release

23 February 2022

 

Gooch & Housego PLC

("G&H" or the "Company")

 

AGM Trading Update

 

"Strong and improving overall demand"

 

Gooch & Housego PLC (AIM: GHH), the specialist manufacturer of photonic components & systems, will hold its Annual General Meeting at 11.00am today at the Company's headquarters in Ilminster, Somerset.

 

During the first four months of the financial year, we have seen strong and improving levels of overall demand and the Group has a record order book across its principal areas of business, industrial lasers, telecoms, A&D and life sciences. There continues to be high demand for industrial lasers, in particular for those used in semiconductor manufacturing, where a combination of high market growth and our new products winning market share has led to substantial growth. Hi-reliability fibre coupler demand remains robust for undersea cables and increasingly for constellation space satellites. Medical lasers continue to benefit from the return of elective surgery and demand for our medical diagnostics products remains high.

 

As at 31 January 2022, our order book stood at a record £110.5 million (31 January 2021: £95.0 million), an increase of 16.3% compared with the same time last year.

 

Pandemic- related factors have restrained trade during the period, these include recruitment, self isolation and supply chain challenges. Mitigating actions are in place. As a result, we expect trading to have a slightly higher second half weighting than anticipated, but the full year outcome to remain unchanged.

 

G&H has continued to invest in our increasingly productive R&D group during the period. We have focused on delivering further innovation through collaborations with the leading companies in their sector.

 

The Company remains in a strong financial position with a robust balance sheet and low levels of net debt.

 

G&H remains committed to the long term goals of further diversification into A&D and life sciences and moving up the value chain. We intend to vigorously pursue these policies through internal investment and where appropriate, acquisitions.

 

 

Mark Webster, Chief Executive Officer of Gooch & Housego, commented:

 

"During the first four months of the financial year we have seen strong and improving levels of overall demand and a record order book across all our principal areas of business. Trading during this period has been constrained by pandemic related factors in some parts of our business, but our outlook for the full year is unchanged.

 

"Fundamental demand for our photonic technologies and system capabilities is strong and improving and we remain confident in the short and long term growth potential for G&H in our target sectors."

 

 

 

A slide deck to accompany the AGM can be viewed at the investor section of the Company's website, https://gandh.com/investors/

 

 

 

 

 

 

 

For further information contact: -

 

Mark Webster/Chris Jewell

Gooch & Housego PLC

01460 256440

Mark Court/Sophie Wills

 

Buchanan

020 7466 5000

Chris Baird/ David Anderson

 

 

 

Investec Bank plc

020 7597 5970

 

Notes to editors

 

1. Gooch & Housego is a photonics technology business headquartered in Ilminster, Somerset, UK with operations in the USA, Europe and China. A world leader in its field, the company researches, designs, engineers and manufactures advanced photonic systems, components and instrumentation for applications in the Aerospace & Defence, Industrial, Life Sciences and Scientific Research sectors. World leading design, development and manufacturing expertise is offered across a broad range of complementary technologies.

 

2. All financial information included in this announcement is sourced from unaudited management accounts and excludes any specific items. This announcement contains certain forward-looking statements that are based on management's current expectations or beliefs as well as assumptions about future events. These are subject to risk factors associated with, amongst other things, the economic and business circumstances occurring from time to time in the countries and sectors in which G&H operates. It is believed that the expectations reflected in these statements are reasonable but they may be affected by a wide range of variables which could cause actual results, and G&H's plans and objectives, to differ materially from those currently anticipated or implied in the forward-looking statements. Investors should not place undue reliance on any such statements. Nothing in this announcement should be construed as a profit forecast.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPPUGCPUPPGQP
Date   Source Headline
8th Feb 202110:20 amRNSHolding(s) in Company
22nd Jan 20214:40 pmRNSSecond Price Monitoring Extn
22nd Jan 20214:35 pmRNSPrice Monitoring Extension
7th Jan 202112:17 pmRNSGrant of LTIP Awards
23rd Dec 20207:00 amRNSLaunch of Satellite Laser Communication System
18th Dec 20207:00 amRNSPosting of Annual Report and AGM Notice
1st Dec 20207:00 amRNSPreliminary Results
16th Nov 20207:00 amRNSNotification of Full Year Results
6th Oct 20207:00 amRNSFull Year Trading Update
2nd Sep 20207:00 amRNSTrading Update
1st Sep 202012:07 pmRNSSecond Price Monitoring Extn
1st Sep 202012:02 pmRNSPrice Monitoring Extension
3rd Jun 20202:53 pmRNSDirector/PDMR Shareholding
2nd Jun 202011:37 amRNSDirector/PDMR Shareholding
2nd Jun 20207:00 amRNSInterim Results
18th May 20207:00 amRNSNotification of Half Year Results
11th May 20207:00 amRNSAppointment of Non-Executive Director
23rd Apr 20204:23 pmRNSHolding(s) in Company
9th Apr 20203:25 pmRNSHolding(s) in Company
7th Apr 20207:00 amRNSHalf Year Trading Update
27th Mar 20204:36 pmRNSPrice Monitoring Extension
24th Mar 20204:42 pmRNSSecond Price Monitoring Extn
24th Mar 20204:36 pmRNSPrice Monitoring Extension
24th Mar 20207:00 amRNSUS Facilities Update
17th Mar 20201:22 pmRNSFremont Facility Update
16th Mar 20201:56 pmRNSDirector/PDMR Shareholding
6th Mar 20209:45 amRNSDirector Share Purchase
3rd Mar 20207:00 amRNSStreamlining of Manufacturing
19th Feb 202012:23 pmRNSResult of AGM
19th Feb 20207:00 amRNSAGM Trading Update
3rd Feb 202012:08 pmRNSIssue of Equity and Total Voting Rights
14th Jan 202010:21 amRNSGrant of LTIP Awards
27th Dec 20193:26 pmRNSDirectorate: David Bauernfeind
11th Dec 20197:00 amRNSPosting of Annual Report and AGM Notice
9th Dec 20198:50 amRNSHolding(s) in Company
3rd Dec 20197:00 amRNSPreliminary Results
20th Nov 20198:42 amRNSBlock listing Interim Review
15th Nov 20194:41 pmRNSSecond Price Monitoring Extn
15th Nov 20194:35 pmRNSPrice Monitoring Extension
11th Nov 201911:18 amRNSConfirmation of Directorate Change
8th Nov 201912:54 pmRNSTotal Voting Rights
7th Oct 20197:00 amRNSFull Year Trading Update and Results Notification
6th Aug 201912:02 pmRNSPrice Monitoring Extension
18th Jul 201910:11 amRNSChief Financial Officer Appointment Timing Update
1st Jul 201910:57 amRNSDirector/PDMR Shareholding
6th Jun 201912:58 pmRNSDirector Share Purchase
4th Jun 20194:23 pmRNSDirectors' Share Purchases
4th Jun 20197:00 amRNSDirectorate Change
4th Jun 20197:00 amRNSInterim Results
28th May 20199:52 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.